BlackRock Inc. boosted its holdings in shares of HMS Holdings Corp (NASDAQ:HMSY) by 7.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,583,749 shares of the business services provider’s stock after buying an additional 759,265 shares during the quarter. BlackRock Inc. owned approximately 13.88% of HMS worth $250,443,000 as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of HMSY. Millennium Management LLC increased its holdings in HMS by 278.2% during the first quarter. Millennium Management LLC now owns 1,289,484 shares of the business services provider’s stock valued at $21,715,000 after buying an additional 948,541 shares during the period. Standard Life Aberdeen plc increased its holdings in HMS by 34.2% during the second quarter. Standard Life Aberdeen plc now owns 1,060,125 shares of the business services provider’s stock valued at $22,915,000 after buying an additional 269,878 shares during the period. DnB Asset Management AS purchased a new position in HMS during the second quarter valued at approximately $4,914,000. Carillon Tower Advisers Inc. purchased a new position in HMS during the first quarter valued at approximately $2,641,000. Finally, Wells Fargo & Company MN increased its holdings in HMS by 76.1% during the first quarter. Wells Fargo & Company MN now owns 344,954 shares of the business services provider’s stock valued at $5,810,000 after buying an additional 149,123 shares during the period. 96.15% of the stock is currently owned by institutional investors.
NASDAQ HMSY traded up $0.10 on Friday, hitting $30.14. The stock had a trading volume of 512,775 shares, compared to its average volume of 497,310. The company has a current ratio of 3.87, a quick ratio of 3.87 and a debt-to-equity ratio of 0.39. HMS Holdings Corp has a 52-week low of $11.01 and a 52-week high of $33.85. The firm has a market capitalization of $2.74 billion, a P/E ratio of 70.09, a P/E/G ratio of 3.92 and a beta of 1.20.
Several brokerages recently issued reports on HMSY. Chardan Capital began coverage on shares of HMS in a report on Thursday, September 13th. They set a “neutral” rating and a $35.00 price objective on the stock. BidaskClub lowered shares of HMS from a “strong-buy” rating to a “buy” rating in a report on Thursday, September 20th. Credit Suisse Group lifted their price objective on shares of HMS from $27.00 to $33.00 and gave the company an “outperform” rating in a report on Wednesday, August 22nd. Zacks Investment Research lowered shares of HMS from a “strong-buy” rating to a “hold” rating in a report on Friday, October 5th. Finally, ValuEngine raised shares of HMS from a “buy” rating to a “strong-buy” rating in a report on Monday, August 13th. Four research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. HMS presently has a consensus rating of “Buy” and an average target price of $30.90.
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. It provides coordination of benefits services to government and commercial healthcare payers and sponsors to coordinate benefits for claims; and payment integrity services that ensure healthcare claims billed are accurate and appropriate, as well as offers care management and consumer engagement solutions.
Featured Article: 52-Week High/Low
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.